RVRC Share Price Performance
US$0.52
0.12 (29.64%)
Price US$0.52
Share PriceUS$0.52
Revium Rx Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
RVRC Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Revium Rx Key Details
About RVRC
- Founded
- 1997
- Employees
- 5
- CEO
- WebsiteView website
Revium Rx, a pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates. It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx was incorporated in 1997 and is based in Herzliya, Israel.
